Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)
Japan · Delayed Price · Currency is JPY 1,092.00
-13.00 (-1.18%)
Jun 4, 2026, 3:30 PM JST
TYO:2395 Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 45,462 | 58,867 | 59,575 | 63,197 | 114,488 | 70,608 | |
Market Cap Growth | -28.16% | -1.19% | -5.73% | -44.80% | 62.15% | 142.63% |
Enterprise Value | 68,553 | 85,331 | 83,708 | 76,950 | 122,470 | 74,176 |
Last Close Price | 1092.00 | 1414.00 | 1385.47 | 1417.11 | 2491.09 | 1508.21 |
PE Ratio | 9.96 | 12.89 | 12.10 | 11.43 | 18.89 | 9.91 |
PS Ratio | 1.40 | 1.81 | 1.84 | 2.39 | 4.56 | 3.98 |
PB Ratio | 1.05 | 1.35 | 1.49 | 1.85 | 4.34 | 3.58 |
P/TBV Ratio | 1.11 | 1.44 | 1.57 | 1.98 | 4.67 | 3.65 |
P/FCF Ratio | 14.42 | 18.67 | - | - | - | 16.01 |
P/OCF Ratio | 5.46 | 7.07 | 8.47 | 30.01 | 28.59 | 11.86 |
EV/Sales Ratio | 2.11 | 2.62 | 2.58 | 2.91 | 4.88 | 4.18 |
EV/EBITDA Ratio | 7.73 | 14.02 | 14.96 | 12.76 | 17.89 | 13.81 |
EV/EBIT Ratio | 12.62 | 32.15 | 28.04 | 18.49 | 23.35 | 17.68 |
EV/FCF Ratio | 21.74 | 27.06 | - | - | - | 16.82 |
Debt / Equity Ratio | 0.95 | 0.95 | 0.86 | 0.77 | 0.71 | 0.46 |
Debt / EBITDA Ratio | 6.78 | 6.78 | 6.16 | 4.34 | 2.74 | 1.70 |
Debt / FCF Ratio | 13.09 | 13.09 | - | - | - | 2.07 |
Net Debt / Equity Ratio | 0.52 | 0.52 | 0.56 | 0.46 | 0.31 | 0.11 |
Net Debt / EBITDA Ratio | 3.73 | 3.73 | 4.01 | 2.58 | 1.20 | 0.40 |
Net Debt / FCF Ratio | 7.21 | 7.21 | -5.88 | -2.40 | -9.86 | 0.49 |
Asset Turnover | 0.33 | 0.33 | 0.38 | 0.40 | 0.52 | 0.47 |
Inventory Turnover | 1.32 | 1.32 | 1.24 | 1.24 | 2.06 | 1.91 |
Quick Ratio | 0.65 | 0.65 | 0.63 | 0.69 | 0.73 | 0.79 |
Current Ratio | 1.09 | 1.09 | 1.13 | 1.31 | 1.14 | 1.21 |
Return on Equity (ROE) | 10.85% | 10.85% | 13.10% | 18.24% | 26.26% | 40.30% |
Return on Assets (ROA) | 1.68% | 1.68% | 2.21% | 3.90% | 6.79% | 6.88% |
Return on Invested Capital (ROIC) | 2.65% | 2.99% | 4.30% | 7.81% | 14.49% | 17.05% |
Return on Capital Employed (ROCE) | 4.00% | 4.00% | 4.70% | 7.90% | 14.50% | 16.20% |
Earnings Yield | 10.05% | 7.76% | 8.27% | 8.75% | 5.29% | 10.09% |
FCF Yield | 6.94% | 5.36% | -6.41% | -10.25% | -0.73% | 6.25% |
Dividend Yield | 4.52% | 3.54% | 3.61% | 3.53% | 2.01% | 1.99% |
Payout Ratio | 45.63% | 45.63% | 42.65% | 37.48% | 41.01% | 11.60% |
Buyback Yield / Dilution | -0.00% | -0.00% | - | - | 0.00% | - |
Total Shareholder Return | 4.57% | 3.53% | 3.61% | 3.53% | 2.01% | 1.99% |